2012
DOI: 10.1016/j.cyto.2012.04.035
|View full text |Cite
|
Sign up to set email alerts
|

Genetic susceptibility to chronic Chagas disease: An overview of single nucleotide polymorphisms of cytokine genes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(18 citation statements)
references
References 53 publications
0
18
0
Order By: Relevance
“…In humans, infection is characterized by 2 phases: an acute phase, which is generally asymptomatic, and a chronic phase, asymptomatic (indeterminate) or symptomatic T. cruzi genetic variability is increasingly recognized and this parasite has been genetically classified into six discrete typing units (DTUs) -TcI to TcVI (Zingales et al, 2009), -which have different geographic distributions and may be associated with geographically-restricted clinical profiles (Tibayrenc and Telleria, 2010). Several data indicate that human genetic determinants may impact the clinical outcome of Chagas disease (Florez et al, 2012;Vasconcelos et al, 2012). However, a role for genetic variability among the different parasite strains in the diverse clinical outcomes of Chagas disease cannot be excluded.…”
Section: Chagas Disease Is a Neglected Tropical Disease Caused By Thementioning
confidence: 99%
“…In humans, infection is characterized by 2 phases: an acute phase, which is generally asymptomatic, and a chronic phase, asymptomatic (indeterminate) or symptomatic T. cruzi genetic variability is increasingly recognized and this parasite has been genetically classified into six discrete typing units (DTUs) -TcI to TcVI (Zingales et al, 2009), -which have different geographic distributions and may be associated with geographically-restricted clinical profiles (Tibayrenc and Telleria, 2010). Several data indicate that human genetic determinants may impact the clinical outcome of Chagas disease (Florez et al, 2012;Vasconcelos et al, 2012). However, a role for genetic variability among the different parasite strains in the diverse clinical outcomes of Chagas disease cannot be excluded.…”
Section: Chagas Disease Is a Neglected Tropical Disease Caused By Thementioning
confidence: 99%
“…Several genes were associated to an increased risk to develop cardiomyopathy (HLA, MHC, TNF, IL1A, IL1B, IL1RN, IL10, IL12B, TIRAP, CCL2, BAT1, LTA, IKBL, CCR5, MIF, IFNG, CXCL9, CXCL10) [25-50]. So far, up to 30 case control studies were done (see for review [51-53]). These studies often led to inconclusive results that may be explained in different ways: a) the use of seronegative subjects as controls which are inadequate controls, since it is unknown whether they were exposed to the pathogen; b) the relatively small size of the study groups which affected the power (the probability) to detect an association; c) the number of tested SNPs; d) the highly heterogeneous genetic background of the study population due to admixture; e) the sex ratio known to exist has not been taken in consideration [54].…”
Section: Introductionmentioning
confidence: 99%
“…However, one study performed in familial clusters in Brazil displayed evidence that genetic factors may influence both, seropositivity and cardiac outcome traits, and additional data showed that heritability were 0.56 . In line with this, several genetic variants of immune genes have been analyzed in endemic populations finding some associations to risk to infection and/or differential predisposition to the severity of Chagas disease . To date, only one genome wide association study (GWAS) has been performed on Chagasic patients; nevertheless, due to technical limitations there was not conclusive results indicating any association to severity of disease .…”
Section: Genotype and Allele Distribution Of Foxo3 Rs12212067 Polymormentioning
confidence: 99%